This study was undertaken to investigate the production of interleukin 1 (IL-1) by pleural leucocytes in culture and to evaluate the influence of intratracheal instillation of crocidolite asbestos on this production. Normal pleural leucocytes spontaneously released IL-1 in culture and stimulation with lipopolysaccharide (LPS) dramatically increased production. Intratracheal instillation with crocidolite asbestos induced recruitment of pleural leucocytes in the longer term and changed IL-1 production by the leucocytes. Reduced production of IL-1 was found by one day after instillation of asbestos and this was correlated with the dose of asbestos. With increasing time after instillation, however, release of IL-1 by pleural leucocytes gradually recovered to normal until, one month after asbestos injection, the leucocytes produced augmented IL-1 in culture compared with control pleural leucocytes. Our data show that pleural leucocytes possess the potential to produce IL-1 in vitro and this capability is altered by intratracheal instillation of crocidolite asbestos. This may be relevant to development of pleural diseases associated with inhalation of asbestos. (British Journal of Industrial Medicine 1993;50:90-94) Interleukin 1 (IL-1) belongs to a family of proteins, the interleukins, which are usually described as performing important regulatory functions between
ponents. 4 Interleukin 1 possesses a wide spectrum of immunological and non-immunological activities including tissue remodelling, repair, and inflammation, by helping to coordinate the activities of many cell types.56
Asbestos has been in widespread industrial use for a long time7 and a large body of evidence has confirmed that inhaled asbestos is associated with many lung disorders such as parenchymal fibrosis (asbestosis) and bronchial carcinoma. 8 The roles of IL-1 in asbestos related lung disorders have been investigated and studies have shown that exposure to asbestos results in abnormal release of IL-1 by macrophages.9 1' Pleural pathological processes, such as effusion, pleural plaques, pleural fibrosis, and mesothelioma," are seen in a proportion of asbestos exposed persons. The effects of asebestos on the activity of pleural leucocytes have not, however, received much attention. Very little is known about the role of cytokines in pleural pathology caused by fibrous dusts such as asbestos.
The objective of this investigation was to study the ability of pleural leucocytes to produce IL-1 in vitro and to assess the influence of crocidolite asbestos, given intratracheally, on this production.
Materials and methods

ANIMALS
Syngeneic PVG rats more than 12 weeks old were obtained from the Institute of Occupational Medicine animal unit.
INTRATRACHEAL INSTILLATION AND PLEURAL LAVAGE
Rats were injected intratracheally with 0-5 ml of phosphate buffered saline (PBS) containing from injection of Nembutal (Ceva, Watford) and the chest wall was exposed. After insertion of a blunt needle into the pleural cavity between two lower ribs, four sequential 5 ml volumes of PBS were injected into the cavity and the chest wall was gently massaged before withdrawal. The cell suspension from the lavage was pooled in plastic containers and kept on ice.
PREPARATIONS OF CELLS AND SUPERNATANTS
The pleural leucocytes were centrifuged and resuspended in F10 medium (Gibco, Paisley) plus 2% bovine serum albumin (BSA, Sigma, Poole). The total cell number from each rat was assessed in a Neubauer chamber. Table 2 shows that with increasing time after the intratracheal injection of 5 mg crocidolite asbestos, the total cell numbers of pleural leucocytes increased significantly compared with those of leucocytes from normal pleura. Considering the change in the proportion of different cell types, the percentage of macrophages declined after injection of asbestos whereas the proportion of eosinophils increased significantly. Other cell types remained at the same level; neutrophils were rarely seen in any of the populations of pleural leucocytes.
The most significant difference arose in that a small number of neutrophils appeared in the pleural cell population when the doses of intratracheally injected crocidolite increased up to 10 mg; however, there were no obvious differences among total cell numbers and the percentages of other components of pleural leucocytes (table 3) . *p < 0-05; **p < 0-01; ***p < 0-001 compared with controls. The measurement of endotoxin in media used in the study indicated a small contamination of endotoxin: F10 + 2% BSA contained 106 pg/ml and PBS 16 pg/ml of endotoxin. There was no detectable endotoxin in RPMI-1640 + 10% FCS and saline.
RELEASE OF IL-I BY CULTURED PLEURAL LEUCOCYTES FROM RATS INTRATRACHEALLY INSTILLED WITH CROCIDOLITE ASBESTOS
Intratracheal instillation of 5 mg crocidolite asbestos resulted in a decrease in activity of IL-1 in the supernatants (fig 2) . One day after injection of asbestos, the IL-1 activity decreased significantly. Time after asbestos instillation (days) Figure 2 Production of IL-I by pleural leucocytesfrom rats at various times after intratracheal instillation of 5 Figure 3 shows the dose related effect of instilled asbestos on production of IL-i1 by pleural leucocytes in culture. The decrease in activity of IL-1 was correlated with the incr-ease in the dose of injected asbestos.
MEASUREMENT OF IL-2 ACTIVITY
To rule out IL-2 as a factor in the thymocyte assay,"4 IL-2 activity was measured with the IL-2 dependent CTLL-2 cell line. Assays of pleural leucocyte supernatants maximally stimulating C3H thymocytes failed to show detectable amounts of IL-2 when tested for their capacity to support CTLL-2 cell growth (data not shown).
Discussion
Although a large body of work has been carried out on production of IL-i by monocytes and macrophages,' few studies have been carried out on pleural leucocytes in this regard. In view of the important role of the pleura in basic lung function and the pleural pathology caused by fibrous dusts, we were interested in the functions of pleural leucocytes after exposure of the airspace to asbestos.
The present study indicates that, without added stimulation, pleural leucocytes from normal rats produced IL-1 in culture. When stimulated with LPS this production increased considerably.
Production of IL-I was decreased when rats received intratracheal administration of crocidolite asbestos and this effect was related to the dose ofasbestos in the lungs. With increasing time after instillation of asbestos, IL-i1 production by the leucocytes returned to normal and was increased over the control values by one month after the instillation.
It has been reported that most normal cell types and some cell lines produce IL-I only in response to various stimulants.'5 Production of IL-1 by normal cells can probably be attributed to a continuing response to previous stimulation in vivo or alternatively, the presence of contaminating endotoxin.
Culture media, blood separation media, FCS, and organic buffer used in culturing IL-I producing cells may contain endotoxin, depending on the source. ' In the present study, low concentrations of contaminating endotoxin were detected, which may contribute to spontaneous production of IL-1 in culture. Despite this background release of IL-1, however, the leucocytes could still be stimulated with LPS to release considerably more IL-1 in culture than controls, which indicates the extensive potential for production of IL-1 by the cells.
The present study indicates that the increased production of IL-1 is concurrent with the recruitment of pleural leucocytes into the pleural space with increasing time after instillation of asbestos. It has been reported that normal alveolar macrophages are at least 1000 times less sensitive to LPS in terms of IL-1 release than blood monocytes. Also, denser alveolar macrophages and blood monocytes released more IL-1 than the less dense components; this dense population is considered to be the less mature monocytic population.'7 18 If young mononuclear phagocytes are the prime source of IL-1, IL-1 release in the pleural space may be regulated, at least in part, by factors that control the influx ofyoung monocytes. In fact, our results show a persistent recruitment of pleural leucocytes with increasing time after exposure to asbestos. As these monocytic cells are continuously recruited into the pleural space, eventually the IL-1 activity released by those cells may exceed control values, as shown in the study.
The changed pattern of release ofpleural leucocyte IL-1 at different stages after deposition of asbestos in the airspace cannot be fully explained by changes in cell populations. We presume, therefore, that the difference in IL-1 production is a result of alteration in cellular activity. Pleural leucocytes are sensitive to stimulation to produce cytokine during culture and, after intratracheal instillation of asbestos in vivo this potential may be modulated or impaired by asbestos fibre in the lungs.
Increasing dose of injected crocidolite resulted in slight changes to the pleural cell population with the appearance of a few neutrophils in the pleural space at the highest dose. A dose related decrease in IL-I production by the leucocytes was, however, present. Because we failed to detect migration of asbestos fibres or other similar size particles into the pleural space after intratracheal instillation, '9 we suggest that the inflammation caused by asbestos in the airspaces may cause the transfer of as yet unidentified inflammatory mediators to the pleural cavity. These may down regulate the ability of pleural leucocytes to release IL-1 in culture.
Normally, there is increased IL-1 release by macrophages exposed to asbestos. Kagan et all' showed that inhalation of either crocidolite or chrysotile asbestos in rats was associated with augmented release of IL-1 by alveolar macrophages. An in vitro study also showed that exposure of peritoneal macrophages to chrysotile asbestos resulted in increased intracellular IL-1 in those cells.9 Long amosite asbestos also stimulates increased release of the cytokine tumour necrosis factor compared to short amosite. 20 In the present study we have shown that asbestos in the airspace results in a decrease in the IL-1 secreting activity of pleural cells. Because deposition of asbestos in the airspace also suppressed production of tumour necrosis factor by pleural leucocytes in culture,'9 this suppression may have some general selective value in the pleural space. Our data on the increased production of plasminogen activator inhibitor after the same type of asbestos treatment2' confirms that the effect is not a general inhibition but suggests that there is selective inhibition of cytokine production by the macrophages. The potency of prostaglandin E2 in inhibiting secretion of IL-122 suggests an autocrine role for this substance.
In the longer term, IL-1 production by pleural leucocytes was increased and this may partly explain the pleural pathology, such as pleural adhesion and pleural fibrosis, seen in persons exposed long term to asbestos." Fibroblasts and their functions, such as raised rates of synthesis of collagen, prostaglandin production, and fibroblast migration, may be stimulated by IL-1. 5 23 Thus the long term increase in production of IL-1 could lead to fibroplasia in the pleura. Increased production of plasminogen activator inhibitor by pleural leucocytes, which we have also shown in the same model,2' could produce a fibrous matrix for fibroblast growth that would encourage fibrous tissue growth.
In summary, the ability of pleural leucocytes to produce IL-1 in culture showed a dose dependent decrease in the acute period after exposure to asbestos; the pleural leucocytes obtained a longer time after exposure, however, showed augmented ability to produce IL-1. These complex changes in production of IL-1 by pleural leucocytes are not understood but may be related to the pleural pathology seen after exposure to asbestos. 
